Page last updated: 2024-09-05

tbc-11251 and Heart Failure

tbc-11251 has been researched along with Heart Failure in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	6 (75.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baicu, CF; Bourge, RC; Little, WC; Redfield, MM; Zhou, D; Zile, MR	1
Colucci, WS; Givertz, MM; Ooi, H	1
Lüscher, TF; Spieker, LE	1
Clark, AL; Cleland, JG; Coletta, AP; Lammiman, M; Loh, H; Nasir, M; Witte, KK	1
Batyraliev, TA; Ekinsi, E; Makhmutkhodzhaev, SA; Pataraia, SA; Pershukov, IV; Preobrazhenskiĭ, DV; Sidorenko, BA	1
Park, MH	1
Wu-Wong, JR	1

Reviews

5 review(s) available for tbc-11251 and Heart Failure

Article	Year
Will endothelin receptor antagonists have a role in heart failure? The Medical clinics of North America, 2003, Volume: 87, Issue:2 Topics: Animals; Bosentan; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Humans; Isoxazoles; Oligopeptides; Peptides, Cyclic; Phenylpropionates; Piperidines; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Thiophenes; Treatment Outcome	2003
Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE. European journal of heart failure, 2005, Volume: 7, Issue:6 Topics: Cardiac Pacing, Artificial; Cardiology; Congresses as Topic; Defibrillators, Implantable; Enalapril; Enoximone; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Isoxazoles; Male; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Societies, Medical; Survival Analysis; Thiophenes; Treatment Outcome	2005
[Pulmonary hypertension and right ventricular failure. Part XI. Endothelin receptor blockers in the treatment of primary pulmonary arterial hypertension]. Kardiologiia, 2007, Volume: 47, Issue:7 Topics: Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Isoxazoles; Phenylpropionates; Pyridazines; Sulfonamides; Thiophenes; Ventricular Dysfunction, Right	2007
Advances in diagnosis and treatment in patients with pulmonary arterial hypertension. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Feb-01, Volume: 71, Issue:2 Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Disease Progression; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelium, Vascular; Epoprostenol; Heart Failure; Humans; Hypertension, Pulmonary; Iloprost; Isoxazoles; Phosphodiesterase Inhibitors; Piperazines; Platelet Aggregation Inhibitors; Prognosis; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Thiophenes; Vasoconstriction	2008
Sitaxsentan (ICOS-Texas Biotechnology). Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:4 Topics: Animals; Clinical Trials as Topic; Endothelin Receptor Antagonists; Heart Failure; Humans; Isoxazoles; Lung Diseases, Obstructive; Receptor, Endothelin A; Subarachnoid Hemorrhage; Thiophenes	2001

Trials

2 trial(s) available for tbc-11251 and Heart Failure

Article	Year
Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction. JACC. Heart failure, 2014, Volume: 2, Issue:2 Topics: Aged; Analysis of Variance; Double-Blind Method; Echocardiography; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Heart Failure; Humans; Isoxazoles; Male; Stroke Volume; Thiophenes; Treatment Outcome; Ventricular Function, Left	2014
Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan. Circulation, 2002, Sep-24, Volume: 106, Issue:13 Topics: Blood Flow Velocity; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Female; Heart Failure; Humans; Hypertension, Pulmonary; Infusions, Intra-Arterial; Isoxazoles; Male; Middle Aged; Pulmonary Artery; Pulmonary Circulation; Receptor, Endothelin A; Reference Values; Thiophenes; Vascular Resistance; Vasomotor System; Ventricular Function, Left	2002

Article

Year

Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction.

JACC. Heart failure, 2014, Volume: 2, Issue:2

Topics: Aged; Analysis of Variance; Double-Blind Method; Echocardiography; Endothelin Receptor Antagonists; Exercise Tolerance; Female; Heart Failure; Humans; Isoxazoles; Male; Stroke Volume; Thiophenes; Treatment Outcome; Ventricular Function, Left

2014

Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.

Circulation, 2002, Sep-24, Volume: 106, Issue:13

Topics: Blood Flow Velocity; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Female; Heart Failure; Humans; Hypertension, Pulmonary; Infusions, Intra-Arterial; Isoxazoles; Male; Middle Aged; Pulmonary Artery; Pulmonary Circulation; Receptor, Endothelin A; Reference Values; Thiophenes; Vascular Resistance; Vasomotor System; Ventricular Function, Left

2002

Other Studies

1 other study(ies) available for tbc-11251 and Heart Failure

Article	Year
TBC 11251. IPI 1040. Drugs in R&D, 1999, Volume: 2, Issue:1 Topics: Animals; Clinical Trials, Phase I as Topic; Drugs, Investigational; Endothelin Receptor Antagonists; Heart Failure; Humans; Isoxazoles; Receptor, Endothelin A; Thiophenes	1999